4 December 2024

Last updated: Wednesday 27 November 2024

Research Directory

New antibiotics pass regulatory hurdles

EU prepares for expansion of biotech

Long overdue, the EU capital markets plan is revived

Swiss biotech helped by international deals, drug wins, By Jane Morrison

GLP-1 agonists shake up the sector

New oncology drugs in pre-registration, late stage development

FDA guidance on drugs for early Alzheimer's disease

Breakthroughs for European bipharma over the horizon

Treating hearing loss as people age

European Biopharma R&D in 2023